JP2006513232A5 - - Google Patents

Download PDF

Info

Publication number
JP2006513232A5
JP2006513232A5 JP2004564537A JP2004564537A JP2006513232A5 JP 2006513232 A5 JP2006513232 A5 JP 2006513232A5 JP 2004564537 A JP2004564537 A JP 2004564537A JP 2004564537 A JP2004564537 A JP 2004564537A JP 2006513232 A5 JP2006513232 A5 JP 2006513232A5
Authority
JP
Japan
Prior art keywords
composition
prostaglandin
compound
dihydro
prostaglandin compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004564537A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006513232A (ja
JP4889219B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2003/016857 external-priority patent/WO2004060377A1/en
Publication of JP2006513232A publication Critical patent/JP2006513232A/ja
Publication of JP2006513232A5 publication Critical patent/JP2006513232A5/ja
Application granted granted Critical
Publication of JP4889219B2 publication Critical patent/JP4889219B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004564537A 2002-12-27 2003-12-26 腹部不快感の処置のためのプロスタグランジン誘導体 Expired - Lifetime JP4889219B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US43646202P 2002-12-27 2002-12-27
US43646302P 2002-12-27 2002-12-27
US60/436,462 2002-12-27
US60/436,463 2002-12-27
PCT/JP2003/016857 WO2004060377A1 (en) 2002-12-27 2003-12-26 Derivatives of prostaglandins for treating abdominal discomfort

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011240314A Division JP2012031202A (ja) 2002-12-27 2011-11-01 腹部不快感の処置のためのプロスタグランジン誘導体

Publications (3)

Publication Number Publication Date
JP2006513232A JP2006513232A (ja) 2006-04-20
JP2006513232A5 true JP2006513232A5 (cg-RX-API-DMAC7.html) 2007-02-15
JP4889219B2 JP4889219B2 (ja) 2012-03-07

Family

ID=32717850

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004564537A Expired - Lifetime JP4889219B2 (ja) 2002-12-27 2003-12-26 腹部不快感の処置のためのプロスタグランジン誘導体
JP2011240314A Pending JP2012031202A (ja) 2002-12-27 2011-11-01 腹部不快感の処置のためのプロスタグランジン誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011240314A Pending JP2012031202A (ja) 2002-12-27 2011-11-01 腹部不快感の処置のためのプロスタグランジン誘導体

Country Status (15)

Country Link
US (3) US7795312B2 (cg-RX-API-DMAC7.html)
EP (2) EP2281564A3 (cg-RX-API-DMAC7.html)
JP (2) JP4889219B2 (cg-RX-API-DMAC7.html)
KR (2) KR20120045051A (cg-RX-API-DMAC7.html)
CN (1) CN1753680B (cg-RX-API-DMAC7.html)
AR (1) AR042670A1 (cg-RX-API-DMAC7.html)
AU (1) AU2003292556B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0317740B8 (cg-RX-API-DMAC7.html)
CA (1) CA2510051C (cg-RX-API-DMAC7.html)
ES (1) ES2591252T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA05006981A (cg-RX-API-DMAC7.html)
NO (1) NO335441B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ541110A (cg-RX-API-DMAC7.html)
TW (1) TWI336254B (cg-RX-API-DMAC7.html)
WO (1) WO2004060377A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
ATE539756T1 (de) * 2002-10-23 2012-01-15 Sucampo Ag Prostaglandinsubstanzen für die behandlung von fettsucht
DE602004030245D1 (de) * 2003-07-03 2011-01-05 Sucampo Ag Pharmazeutische magensaftresistent überzogene zusammensetzung enthaltend prostaglandin-analoga als chloridkanalöffner
TWI387454B (zh) * 2004-09-02 2013-03-01 蘇坎波公司 治療胃腸道疾病之方法及組成物
CN101180096B (zh) * 2005-03-21 2015-04-22 苏坎波公司 用于治疗粘膜疾病的方法和组合物
US20060281818A1 (en) * 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
KR20140069182A (ko) * 2005-04-12 2014-06-09 수캄포 아게 위장 장애 치료를 위한 프로스타글란딘 화합물과 양성자 펌프 억제제의 병용
WO2008029949A1 (en) 2006-09-06 2008-03-13 Sucampo Ag Method and composition for promoting gastrointestinal bicarbonate secretion
EP2114411A2 (en) * 2007-02-27 2009-11-11 Sucampo AG Composition and method for protecting mitochondria
US20090012165A1 (en) 2007-07-03 2009-01-08 Sucampo Ag Pharmaceutical combination of nsaid and prostaglandin compound
US20090030072A1 (en) * 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound
WO2011035142A1 (en) * 2009-09-18 2011-03-24 Adolor Corporation Use of opioid receptor antagonist for gastrointestinal tract disorders
IT1402047B1 (it) * 2010-10-19 2013-08-28 Cross Pharma Sa Uso del mexiprostil nel trattamento delle malattie infiammatorie intestinali
JO3438B1 (ar) 2011-04-13 2019-10-20 Epizyme Inc مركبات بنزين مستبدلة بأريل أو أريل غير متجانس
CN108685929A (zh) * 2012-04-23 2018-10-23 苏坎波公司 用于治疗具有腹泻的肠易激综合征的方法
AU2013331380B2 (en) 2012-10-15 2018-03-22 Epizyme, Inc. Substituted benzene compounds
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1581886A (en) * 1977-05-26 1980-12-31 May & Baker Ltd Prostanol derivatives
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
CA1322749C (en) 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5221763A (en) 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
JPH0681728B2 (ja) * 1987-10-02 1994-10-19 株式会社上野製薬応用研究所 下 剤
US5317032A (en) 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
JP2579193B2 (ja) 1988-07-19 1997-02-05 小野薬品工業株式会社 16,16−ジフルオロ−15−オキソ−15−デオキシpge誘導体
CA2039420C (en) 1990-04-04 1996-12-10 Ryuji Ueno Treatment of cataract with 15-keto-prostaglandin compounds
EP0455448B1 (en) 1990-05-01 1998-12-09 R-Tech Ueno Ltd. Treatment of pancreatic disease with 15-keto-prostaglandin E compounds
CA2150287C (en) 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
WO1997047595A1 (en) 1996-06-10 1997-12-18 R-Tech Ueno, Ltd. Endothelin antagonist
US6046239A (en) * 1997-08-05 2000-04-04 American Home Products Corporation Anthranilic acid analogs
ES2310013T3 (es) * 1997-11-28 2008-12-16 Sucampo Ag Uso de compuestos de 15-ceto-prostaglandina e como antagonistas de endotelina.
US6492417B1 (en) * 1997-12-22 2002-12-10 Alcon Manufacturing, Ltd. 11-deoxy-16-fluoro-PGF2α analogs as FP receptor antagonists
DK1426361T4 (en) 1999-10-15 2015-03-16 Sucampo Ag Novel compounds containing a bi-cyclic compound and a glyceride
EP1267883B1 (en) * 2000-04-06 2009-06-17 Sucampo AG Bile secretion promoting composition for liver transplantation containing a 15-keto-prostaglandin
US6414016B1 (en) 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI302100B (en) * 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
CA2445651C (en) * 2001-05-18 2011-08-09 Sucampo Ag Cathartic composition comprising halogenated prostaglandin derivatives
BR0212233A (pt) * 2001-08-31 2004-10-05 Sucampo Ag Abridor de canal de cloreto
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
TWI263505B (en) * 2001-11-19 2006-10-11 Sucampo Ag Pharmaceutical composition comprising a C1C-2 channel opener

Similar Documents

Publication Publication Date Title
JP2006513232A5 (cg-RX-API-DMAC7.html)
CN1133434C (zh) 作为治疗剂的环戊烷庚烷(烯)酸、2-杂芳基链烯基衍生物
CN100335049C (zh) 泻药组合物
JP4044967B2 (ja) 11,15−o−ジアルキルプロスタグランジンe誘導体、それらの製造方法およびそれらを有効成分として含有する薬剤
KR100349964B1 (ko) ω-시클로알킬 프로스타글란딘 E1 유도체
JP2004527567A5 (cg-RX-API-DMAC7.html)
JPWO1998034916A1 (ja) 11,15−o−ジアルキルプロスタグランジンe誘導体、それらの製造方法およびそれらを有効成分として含有する薬剤
JPH10265454A (ja) 3,7−ジチアプロスタン酸誘導体、それらの製造方法およびそれらを有効成分として含有する薬剤
WO1998012175A1 (en) Fluorinated prostaglandin derivatives and medicines
JP2004507521A5 (cg-RX-API-DMAC7.html)
JP6052175B2 (ja) 左室拡張機能改善剤
WO2004065365A1 (ja) 8−アザプロスタグランジン誘導体およびその医薬用途
US7652063B2 (en) 10-hydroxy-11-dihydroprostaglandin analogs as selective EP4 agonists
JP2007512252A (ja) 緑内障および関連疾患を処置するための新規プロスタミド
JP2006506381A5 (cg-RX-API-DMAC7.html)
JP2004529960A5 (cg-RX-API-DMAC7.html)
CN1273140C (zh) 导泻组合物
WO1999027934A1 (fr) Antagoniste d'endotheline
JP2008528440A5 (cg-RX-API-DMAC7.html)
JP2004519412A5 (cg-RX-API-DMAC7.html)
JP2007518685A5 (cg-RX-API-DMAC7.html)
JP2004529177A5 (cg-RX-API-DMAC7.html)
JP2004538306A5 (cg-RX-API-DMAC7.html)
CN106458859B (zh) 作为治疗性化合物的新型ep4激动剂
JP2004521960A5 (cg-RX-API-DMAC7.html)